Complete randomized experimental design has been a popular standard in clinical trials due to its abilities to yield a smaller bias and to provide a strong foundation for statistical inferences. However, because of ethical issues, there is a growing demand for response adaptive designs which shift the allocation probabilities such that more patients receive the better treatment. The principal idea of response adaptive designs to allocate fewer patients to treatments which appears to be inferior based on the accruing response data and information collected up to the current stage. Although they are more complex than complete randomized experiments in theory and method, adaptive designs are practically more useful. The objective of this disse...
We propose a response-adaptive design, described in terms of urn model, whose allocation proportion ...
The primary goal of clinical trials is to collect enough scientific evidence for a new intervention....
PhDPrevious work on two-treatment comparisons has shown that the use of optimal response-adaptive r...
Abstract: Urn models are popular and useful for adaptive designs in clinical studies. Among various ...
Modern medical experiments accrue and treat patients--hence obtain treatment response data--througho...
International audienceIn controlled clinical trials, where minimizing treatment failures is crucial,...
We consider a problem of reducing the expected number of treatment failures in trials where the prob...
Response-adaptive designs are being used increasingly in applications, and this is especially so in ...
Modern medical experiments accrue and treat patients—hence obtain treatment response data—throughout...
Response-adaptive designs are being used increasingly in applications, and this is especially so in ...
Clinical trials have traditionally followed a fixed design, in which randomization probabilities of ...
Response-adaptive (RA) allocation designs can be implemented in clinical trials to skew the allocati...
We propose a response-adaptive design, described in terms of urn model, whose allocation proportion ...
The primary goal of clinical trials is to collect enough scientific evidence for a new intervention....
PhDPrevious work on two-treatment comparisons has shown that the use of optimal response-adaptive r...
Abstract: Urn models are popular and useful for adaptive designs in clinical studies. Among various ...
Modern medical experiments accrue and treat patients--hence obtain treatment response data--througho...
International audienceIn controlled clinical trials, where minimizing treatment failures is crucial,...
We consider a problem of reducing the expected number of treatment failures in trials where the prob...
Response-adaptive designs are being used increasingly in applications, and this is especially so in ...
Modern medical experiments accrue and treat patients—hence obtain treatment response data—throughout...
Response-adaptive designs are being used increasingly in applications, and this is especially so in ...
Clinical trials have traditionally followed a fixed design, in which randomization probabilities of ...
Response-adaptive (RA) allocation designs can be implemented in clinical trials to skew the allocati...
We propose a response-adaptive design, described in terms of urn model, whose allocation proportion ...
The primary goal of clinical trials is to collect enough scientific evidence for a new intervention....
PhDPrevious work on two-treatment comparisons has shown that the use of optimal response-adaptive r...